NetworkNewsBreaks

WednesdayFeb 10, 2021 10:14 am

NetworkNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Studying Potential for Psychedelics in Treatment of Mental Health Conditions, Announces Addition of Mescaline to Subsidiary Medicine Programs

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator at the leading-edge of the life science industry, is involved in preclinical laboratory work designed to study a variety of psychotropic compounds, including psilocybin, mescaline, LSD, MDMA and DMT. The company also announced that its subsidiary, XPhyto Laboratories Inc., has added the production of mescaline to its psychedelic medicine programs. These psychedelic compounds show promising potential in treating mental conditions because they are known to modulate neurotransmitters such as serotonin and dopamine, which regulate cognition, perception and mood in individuals. Called a leader in innovating psychedelic drugs in a recent…

Continue Reading

WednesdayFeb 10, 2021 10:06 am

NetworkNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Announces First Commercial Contract for CBD Oil

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company specializing in cannabis, hemp and mushroom products, has contracted for its initial commercial CBD oil sale. The company anticipated the contract will result in multiple shipments of its 85% pure CBD distillate offering this year. Pure Extracts’ state-of-the-art, subcritical/super-critical CO2 extraction system produces an exceptionally pure THC and CBD full-spectrum oil and distillate. The resulting distillate can be used to manufacture a variety of cannabis 2.0 products, such as beverages, edibles and vape pens. The announcement also noted that Pure Extracts continues its commitment to increase awareness.…

Continue Reading

WednesdayFeb 10, 2021 9:31 am

NetworkNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Preparing Phase 3 Trial to Evaluate Neuroactive Nasal Spray Treatment for SAD

VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company developing new-generation medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (“CNS”) disorders, has announced plans to begin a Phase 3 clinical trial in Q2 2021. The clinical trial will evaluate PH94B (“PH94B”), a neuroactive nasal spray designed to provide rapid onset of action for the acute treatment of anxiety in adults with social anxiety disorder (“SAD”). With an estimated 20 million people in the United States suffering from SAD, it is one of the most prevalent mental health conditions in the…

Continue Reading

TuesdayFeb 09, 2021 2:48 pm

NetworkNewsBreaks – PowerBand Solutions Inc.’s (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA) DRIVRZ(TM) Offers End-to-End Transportation Products and Services

PowerBand Solutions (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA), a fintech provider disrupting the automotive industry, today announced the capabilities of its DRIVRZ(TM) platform. DRIVRZ(TM) is distinctly different than traditional online auto services, offering a 360-degree, protected, full-service experience including end-to-end purchasing, leasing, trade negotiating, financing, protection products, home delivery, satisfaction guarantee return policies, transactional support, and ombudsmen resolution solutions. The platform also gives the consumer to option to work with a local dealer. "Buying a product online is one thing, but buying transportation online is serious business" said PowerBand's President Jon Lamb. "The consortium of service providers we have contracted…

Continue Reading

TuesdayFeb 09, 2021 2:00 pm

NetworkNewsBreaks – Siyata Mobile Inc. (NASDAQ: SYTA) (TSX.V: SIM) Announces New Chairman, Member to Board of Directors

Siyata Mobile (NASDAQ: SYTA, SYTAW) (TSX.V: SIM), a leading global developer and provider of Push-to-Talk Over Cellular (“PTT/PoC”) systems for enterprise customers, has appointed Peter Goldstein, currently a Siyata Board member, as chairman of its Board of Directors; the company also named Luisa Ingargiola as a new board members; the appointment will be effective as of Feb. 23, 2021. Ingargiola has extensive experience on public company boards and in the capital markets. Goldstein has served for more than 30 years as a C-suite executive for public and private companies. He is also the founder, chairman and CEO of Grandview Capital…

Continue Reading

TuesdayFeb 09, 2021 1:47 pm

NetworkNewsBreaks – ECGI Holdings Inc. (ECGI) Announces Creation of New Subsidiary, Plans to Enter Cannabis Delivery Business

ECGI Holdings (OTC: ECGI), which plans to operate as Elite Cannabis Group and has been reorganized as an acquisition-oriented corporation with California-based targets of distressed cannabis assets, properties zoned for cannabis cultivation and processing, today announced its second agreement within the fast-growing California regulated cannabis market. According to the update, the company has signed a definitive management services agreement to enter the cannabis delivery business in conjunction with a California cannabis license holder operating out of Lynwood, California. ECGI created Nug Avenue Inc., a wholly owned subsidiary that will hold the contract with the licensed party. “We are continuing to…

Continue Reading

TuesdayFeb 09, 2021 1:19 pm

NetworkNewsBreaks – Kaival Brands Innovations Group Inc. (KAVL) Announces Bidi Vapor Received FDA PMTA Acceptance Letter for all 11 Bidi Stick Products

Kaival Brands (OTCQB: KAVL), a company focused on generating shareholder value by incubating innovative products into mature and dominant brands within their respective markets, has announced that Bidi(R) Vapor has received a PMTA acceptance letter from the U.S. Food and Drug Administration (“FDA”). Kaival is the exclusive global distributor of Bidi Vapor LLC products. The PMTA letter marks an important milestone Bidi’s overall application is one step closer to meeting the FDA’s baseline criteria before moving into the substantive review, which is the final phase of the PMTA process. The PMTAa for Bidi Vapor now move on to the filing review…

Continue Reading

TuesdayFeb 09, 2021 1:07 pm

NetworkNewsBreaks – GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS) Commences Phase I Drill Campaign at Rio Loa

GoldHaven Resources (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS), a Canada-based company engaged in the business of acquiring and exploring mineral resource properties, today announced that the drill crew has been mobilized over the weekend and has commenced its 5,000-meter Phase I drill campaign starting at Rio Loa. The Rio Loa Project is located 25 km south of Gold Field's Salares Norte deposit (5.2 million ounces equivalent of Gold scheduled to produce 350,000 oz of Gold per annum) and 6 km south of Gold Field's Horizonte discovery. "This is a major milestone in our development to unlock the potential of our…

Continue Reading

TuesdayFeb 09, 2021 12:15 pm

NetworkNewsBreaks – Spectrum Global Solutions Inc. (SGSI) Announces High Wire’s Achievement of SOC 2 Type 1 Certification

Spectrum Global Solutions (OTCQB: SGSI), a single-source provider of next-generation communications network and professional services to telecommunications and enterprise markets, today announced that High Wire Networks Inc. and its cybersecurity business unit, Overwatch Managed Security, have achieved SOC 2 Type 1 certification. According to the update, SOC 2 is a technical audit that requires companies to establish strict information security policies and procedures to protect customer data. “SOC 2 Type 1 certification proves High Wire’s information security measures are in line with the unique parameters of today’s cloud requirements and that systems for shared access to the cloud are safely…

Continue Reading

TuesdayFeb 09, 2021 12:05 pm

NetworkNewsBreaks — MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) Releases Further Lab Results Validating Natural Biopesticide Control of Banana Disease

MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0), an agriculture biotech company focused on providing natural science-based biological solutions for high-value crops, as released additional lab results confirming its mustard-derived natural biopesticide ability to obtain 100% control of on the disease Fusarium wilt TR4. A banana disease often referred to as the Panama disease, Fusarium wilt TR4 is destroying the $25 billion global banana industry. These most-recent results were conducted by a third party and validate earlier test results that confirm the efficacy of MustGrow’s safe and effective natural, plant-based biopesticide. The test results confirm 100% control achieved at economic…

Continue Reading